Login or sign up
For business
Average ratingGreat
4.0/ 5

Based on 11 reviews

536%
427%
336%
20%
10%
Ask AI

Ask AI about Assertio

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Syl Mauro
Reviews 1

I recently had the pleasure of utilizing the services of this company, and I must say that I was thoroughly impressed with the level of professionalism and expertise displayed throughout the entire process. The team was incredibly knowledgeable and helpful, guiding me through every step with patience and care. The website was user-friendly and provided me with all the information I needed to make informed decisions. The attention to detail and commitment to customer satisfaction were evident in every interaction I had with the company. Overall, I am extremely satisfied with the exceptional service I received, and I would highly recommend this company to anyone in need of their services.

Rachel Heep
Reviews 1

I ordered a product from Assertio and I am really impressed with their service. The website is user-friendly and the checkout process was smooth. The product was delivered on time and it met my expectations. I would definitely recommend Assertio to others. Great job!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Assertio

Assertio is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. The company was founded in 1995 and has established itself by developing and incorporating promising technology into differentiated therapeutic products, taking those products through clinical approval, and building a strong market presence. The company currently markets four FDA-approved products, Gralise® (gabapentin) tablets for the management of Postherpetic Neuralgia (PHN), Cambia® (diclofenac potassium for oral solution) for acute treatment of migraine attacks with or without aura in adults 18 years of age or older, Zipsor® (diclofenac potassium) liquid filled capsules for relief of mild to moderate acute pain, and Lazanda® (fentanyl) nasal spray CII for the management of breakthrough pain in cancer patients. See Important Safety Information for Gralise, Cambia, Zipsor, and Lazanda.

Address
100 south saunders road
Categories
Pharmaceuticals